... and was the primary efficacy endpoint of the trial. Use of the drug-eluting stent also resulted in a significant 56% reduction ... of the uncertainty and concern about the efficacy and safety of drug-eluting stents in this clinical setting. Moreover, all of the patients ...
... in the first 30 days for people with drug eluting stents was significantly lower than for those with bare metal ... and hypertension. "Our study findings suggest that drug eluting stents, despite recent concerns surrounding ...
... ) and are more prone to reclog than larger vessels. The use of drug-eluting stents in the tiny infrapopliteal arteries of the leg ... requiring repeat angioplasty, said Karnabatidis. "In the drug-eluting stent group, an estimated 60 percent ...
... through 2006. Most of the patients had received a drug-eluting stent; only 17 percent were implanted with the bare ... . They found that over the 30-month period, patients in the drug-eluting stent group had a 25 percent reduction ...
Drug-eluting stents were safe and superior to bare metal stents in preventing death and heart attacks among 262,700 "real-world" patients enrolled in a nationwide registry of cardiovascular disease.
... . "To draw definitive conclusions about the safety of drug eluting stents, what is really needed, is a large ... a strong argument of the cost effectiveness of drug eluting stents. "What also needs to be remembered is that preventing ...
NEW YORK, May 11 (UPI) -- A U.S. study has determined drug-eluting stents are more effective than, and equally as safe as, bare-metal stents.
... and stroke established the non-inferiority of drug-eluting stents with respect to safety through one year ... of the uncertainty and concern about the efficacy and safety of drug-eluting stents in this clinical setting. Moreover, all of the patients ...
... ) announced that results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) were published online June ...
... immediate change in clinical practice for drug-eluting stents, according to a study reported in Circulation: Cardiovascular ... . By the end of March 2007, the use of drug-eluting stents fell to 67 percent and usage continued ...
... after the initial six months in patients with drug eluting stents and we concluded that a generalized use of DES should ... risk of death or myocardial infarction with drug eluting stents with a surprisingly low reduction in revascularization ...
... years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare ... to focus on the appropriate use of anticoagulation medications and drug-eluting stents in patients experiencing the most dangerous form ...
... and freedom from major amputations. The placement of drug-eluting stents in the infrapopliteal leg arteries is safe ... and the continued progression of atherosclerotic disease. Drug-eluting stents are a potential solution to the limitations of endovascular ...
Increased use of drug-eluting stents (DES) and implantable cardioverter-defibrillators (ICDs) between 2003 and 2006 netted significantly ...
... Medical Center in Israel have determined that the use of drug-eluting stents (DES) improves the long-term clinical outcome for patients undergoing percutaneous ...
